Market Overview:
The global hyaluronic acid for osteoarthritis market is expected to grow at a CAGR of 5.8% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of osteoarthritis, rising awareness about the benefits of hyaluronic acid injections for treating osteoarthritis, and technological advancements in the field of orthopedics. The global hyaluronic acid for osteoarthritis market can be segmented on the basis of type into single-phase and duplex. The single-phase segment is expected to account for a larger share of the global market than the duplex segment during the forecast period. On the basis of application, this market can be divided into knee joint, hip joint, shoulder joint, ankle joint, and others (elbow joints and fingers). The knee joint application segment is expected to account for a larger share of this market than other application segments during 2018–2030 owing to its high prevalence rate globally.
Product Definition:
Hyaluronic acid is a substance that is naturally found in the body. It helps to cushion and lubricate joints. People with osteoarthritis often have lower levels of hyaluronic acid in their joints. Some research suggests that taking hyaluronic acid supplements may help reduce pain and improve function in people with osteoarthritis.
Single-Phase:
Single-phase is a method of processing hyaluronic acid that has been used for many years. It is the most commonly used method in the industry and has been successful in treating osteoarthritis, but recently there have been some concerns raised about its safety and effectiveness. The single-phase process uses sodium salt (NaCl) as a coagulation agent to create micro-crystalline hyaluronic acid (HA).
Duplex:
Duplex is a biopharmaceutical company engaged in the development of hyaluronic acid based therapeutics for osteoarthritis. The company has developed two products, namely duplex and DUA-34 that are currently under phase III clinical trials. Duplex has formulated an orphan drug application with the U.
Application Insights:
The knee joint application segment led the global market in 2017. The increasing prevalence of osteoarthritis is one of the major factors driving this segment. According to a study published by Osteoarthritis Research Society International, in 2014, it was estimated that around 54 million people aged over 50 years have osteoarthritis pain and this number is expected to increase to 64 million by 2050.
Hyaluronic acid injections are used for treating osteoarthritis as well as rheumatoid arthritis due to its cartilage-friendly properties. These benefits include reduced inflammation and improved mobility of joints which help reduce pain and stiffness caused due these diseases. In addition, hyaluronic acid also helps improve physical function along with reducing dependency on other medications which makes it an attractive treatment option for patients suffering from these conditions globally as well as across different regions including North America, Europe, Asia Pacific and Middle East & Africa countries mentioned above.
Regional Analysis:
North America dominated the global market in 2017 owing to the high prevalence of osteoarthritis and advanced healthcare infrastructure. Moreover, rising geriatric population is also expected to drive regional growth over the forecast period. Asia Pacific region is anticipated to witness lucrative growth during the forecast period due to increasing disposable income, growing medical tourism and favorable government initiatives for R&D in this region. In addition, a large number of companies are investing huge amounts in this sector due to which it has become one of the promising markets for investors as well as manufacturers. For instance, Novotech invested USD X million per year from 2016 until 2018 on R&D activities related hyaluronic acid products used by physicians around world including knee joint pain treatment (Novotech SpA).
In addition, Asian countries such as China and India have a large patient pool that requires effective treatment options for osteoarthritis conditions; hence driving demand across this region (Novotech SpA).
Growth Factors:
- Increasing geriatric population: The global geriatric population is increasing at a rapid pace. This is expected to drive the demand for hyaluronic acid for osteoarthritis treatment, as this population is more susceptible to the condition.
- Rising awareness about hyaluronic acid therapy: There has been a rise in the awareness about hyaluronic acid therapy in recent years, which is likely to boost the market growth.
- Technological advancements: The development of new and innovative technologies for HA production is anticipated to propel market growth over the forecast period.
- Growing demand from emerging markets: The demand for HA products is growing rapidly in emerging markets such as China and India due to rising income levels and an increase in health consciousness among consumers.. This will create lucrative opportunities for players operating in this market over the forecast period.. 5) Availability of reimbursement policies: Reimbursement policies related to HA products are becoming increasingly favourable, which will spur market growth during the forecast period
Scope Of The Report
Report Attributes
Report Details
Report Title
Hyaluronic Acid for Osteoarthritis Market Research Report
By Type
Single-Phase, Duplex
By Application
Knee Joint, Hip Joint, Shoulder Joint, Ankle Joint, Others
By Companies
BIOVENTUS, Sanofi, Ferring B.V., Anika Therapeutics, Fidia Farma, LG Chem, Bohus BioTech, Hangzhou Singclean Medical Products, Biolevox, Vivacy, BIOVENTUS, Xediton Pharmaceuticals, Deka, BIOIBERICA
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
180
Number of Tables & Figures
126
Customization Available
Yes, the report can be customized as per your need.
Global Hyaluronic Acid for Osteoarthritis Market Report Segments:
The global Hyaluronic Acid for Osteoarthritis market is segmented on the basis of:
Types
Single-Phase, Duplex
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Knee Joint, Hip Joint, Shoulder Joint, Ankle Joint, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- BIOVENTUS
- Sanofi
- Ferring B.V.
- Anika Therapeutics
- Fidia Farma
- LG Chem
- Bohus BioTech
- Hangzhou Singclean Medical Products
- Biolevox
- Vivacy
- BIOVENTUS
- Xediton Pharmaceuticals
- Deka
- BIOIBERICA
Highlights of The Hyaluronic Acid for Osteoarthritis Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Single-Phase
- Duplex
- By Application:
- Knee Joint
- Hip Joint
- Shoulder Joint
- Ankle Joint
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Hyaluronic Acid for Osteoarthritis Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Hyaluronic acid is a natural substance that helps to keep the cartilage in your joints healthy. When you have osteoarthritis, your cartilage becomes thin and brittle. Hyaluronic acid can help to keep the cartilage strong and flexible, which can help to improve joint function.
Some of the key players operating in the hyaluronic acid for osteoarthritis market are BIOVENTUS, Sanofi, Ferring B.V., Anika Therapeutics, Fidia Farma, LG Chem, Bohus BioTech, Hangzhou Singclean Medical Products, Biolevox, Vivacy, BIOVENTUS, Xediton Pharmaceuticals, Deka, BIOIBERICA.
The hyaluronic acid for osteoarthritis market is expected to register a CAGR of 5.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Hyaluronic Acid for Osteoarthritis Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Hyaluronic Acid for Osteoarthritis Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Hyaluronic Acid for Osteoarthritis Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Hyaluronic Acid for Osteoarthritis Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Hyaluronic Acid for Osteoarthritis Market Size & Forecast, 2020-2028
4.5.1 Hyaluronic Acid for Osteoarthritis Market Size and Y-o-Y Growth
4.5.2 Hyaluronic Acid for Osteoarthritis Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Single-Phase
5.2.2 Duplex
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Knee Joint
6.2.2 Hip Joint
6.2.3 Shoulder Joint
6.2.4 Ankle Joint
6.2.5 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Hyaluronic Acid for Osteoarthritis Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Hyaluronic Acid for Osteoarthritis Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Single-Phase
9.6.2 Duplex
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Knee Joint
9.10.2 Hip Joint
9.10.3 Shoulder Joint
9.10.4 Ankle Joint
9.10.5 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Single-Phase
10.6.2 Duplex
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Knee Joint
10.10.2 Hip Joint
10.10.3 Shoulder Joint
10.10.4 Ankle Joint
10.10.5 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Single-Phase
11.6.2 Duplex
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Knee Joint
11.10.2 Hip Joint
11.10.3 Shoulder Joint
11.10.4 Ankle Joint
11.10.5 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Single-Phase
12.6.2 Duplex
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Knee Joint
12.10.2 Hip Joint
12.10.3 Shoulder Joint
12.10.4 Ankle Joint
12.10.5 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Single-Phase
13.6.2 Duplex
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Knee Joint
13.10.2 Hip Joint
13.10.3 Shoulder Joint
13.10.4 Ankle Joint
13.10.5 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Hyaluronic Acid for Osteoarthritis Market: Competitive Dashboard
14.2 Global Hyaluronic Acid for Osteoarthritis Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 BIOVENTUS
14.3.2 Sanofi
14.3.3 Ferring B.V.
14.3.4 Anika Therapeutics
14.3.5 Fidia Farma
14.3.6 LG Chem
14.3.7 Bohus BioTech
14.3.8 Hangzhou Singclean Medical Products
14.3.9 Biolevox
14.3.10 Vivacy
14.3.11 BIOVENTUS
14.3.12 Xediton Pharmaceuticals
14.3.13 Deka
14.3.14 BIOIBERICA
